This information was provided by prnewswire
Send your Press Release here.
VANCOUVER, Oct. 10, 2018 /CNW/ – InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (TSX: IN; OTCQX: IMLFF), a fully integrated, cannabinoid-based biopharmaceutical company that leverages its proprietary bioinformatics and biosynthesis platform technologies to develop novel therapeutics for the treatment of diseases with high unmet medical needs, will be presenting at the BIO Investor Forum on Wednesday, October 17, 2018 at 9:30 AM PT / 12:30 PM ET at the Westin St. Francis, in San Francisco, California. The presentation will be webcast, the link to which may be found on the Company’s website, or below.
Conference Call & Webcast:
Wednesday, Oct. 17, 2018 at 9:30 AM Pacific Time, 12:30 PM Eastern Time
Webcast replay available: 1 hour after conclusion of live event
Webcast replay expires: January 15, 2019